ATHIRA PHARMA

athira-pharma-logo

Athira Pharma is a clinical-stage drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders. Athira is derived from the word Athir, the energy that reaches everyone. It captures its mission to develop therapies that can reach and positively impact everyone.

#SimilarOrganizations #People #Financial #Event #Website #More

ATHIRA PHARMA

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2011-01-01

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.athira.com

Total Employee:
11+

Status:
Active

Contact:
(206) 221-8112

Email Addresses:
[email protected]

Total Funding:
233.6 M USD

Technology used in webpage:
SPF Apple Mobile Web Clips Icon Google Universal Analytics Microsoft Exchange Online Office 365 Mail YouTube Sectigo SSL Sectigo Domain SSL Pound Sterling Japanese Yen


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

medigene-logo

MediGene

MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.

translate-bio-logo

Translate Bio

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

x4-pharmaceuticals-logo

X4 Pharmaceuticals

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.


Current Advisors List

joseph-edelman_image

Joseph Edelman Board Member @ Athira Pharma
Board_member
2020-06-01

joseph-harding_image

Joseph Harding Board of Director @ Athira Pharma
Board_member

james-a-johnson_image

James A. Johnson Board Member @ Athira Pharma
Board_member
2020-08-01

amber-caska_image

Amber Caska Advisor @ Athira Pharma
Advisor
2018-01-01

Current Employees Featured

joseph-harding_image

Joseph Harding
Joseph Harding Chief Scientific Officer @ Athira Pharma
Chief Scientific Officer

rachel-lenington_image

Rachel Lenington
Rachel Lenington Chief Operating Officer @ Athira Pharma
Chief Operating Officer
2021-10-01

mark-litton_image

Mark Litton
Mark Litton President & Chief Executive Officer @ Athira Pharma
President & Chief Executive Officer
2021-10-01

kelly-romano_image

Kelly Romano
Kelly Romano Independent Director - Board of Directors @ Athira Pharma
Independent Director - Board of Directors
2020-12-01

mark-worthington_image

Mark Worthington
Mark Worthington General Counsel @ Athira Pharma
General Counsel
2021-06-01

Founder


joseph-harding_image

Joseph Harding

leen-kawas_image

Leen Kawas

lewis-rumpler_image

Lewis Rumpler

Stock Details


Company's stock symbol is NASDAQ:ATHA

Investors List

national-institute-on-aging_image

National Institute on Aging

National Institute on Aging investment in Grant - Athira Pharma

primer-capital_image

Primer Capital

Primer Capital investment in Convertible Note - Athira Pharma

avidity-partners_image

Avidity Partners

Avidity Partners investment in Series B - Athira Pharma

viking-global-investors_image

Viking Global Investors

Viking Global Investors investment in Series B - Athira Pharma

highline-capital-management_image

Highline Capital Management

Highline Capital Management investment in Series B - Athira Pharma

franklin-templeton-investments_image

Franklin Templeton Investments

Franklin Templeton Investments investment in Series B - Athira Pharma

venrock-healthcare-partners_image

Venrock Healthcare Capital Partners

Venrock Healthcare Capital Partners investment in Series B - Athira Pharma

rick-kayne_image

Rick Kayne

Rick Kayne investment in Series B - Athira Pharma

suzanne-kayne_image

Suzanne Kayne

Suzanne Kayne investment in Series B - Athira Pharma

ditch-plains-capital-management_image

Ditch Plains Capital Management LP

Ditch Plains Capital Management LP investment in Series B - Athira Pharma

Official Site Inspections

http://www.athira.com

  • Host name: 45.60.98.212
  • IP address: 45.60.98.212
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Athira Pharma" on Search Engine